Toxins
|
May 31, 2024

Lipopolysaccharides: Strategies for Treating Endotoxin-Induced Health Issues

Medically Reviewed by
Updated On
September 17, 2024

Lipopolysaccharides (LPS), or endotoxins, are components of the outer membrane of Gram-negative bacteria that can provoke significant immune responses when they enter the human body, leading to various health issues. 

This article discusses the health impacts of LPS exposure and strategies for treating conditions caused by endotoxin exposure, encompassing both medical and lifestyle interventions. 

[signup]

What Are Lipopolysaccharides (LPS)? 

Lipopolysaccharides (LPS) are components of the outer cell membrane of gram-negative bacteria. The gram-negative bacterial cell membrane consists of an inner and outer membrane. LPS molecules are considered bacterial toxins. When they enter the body during an infection they can trigger a severe immune reaction.

LPS are composed of three main parts, Lipid A, which is the most virulent factor, O-antigen, and a hydrophilic core. The O-antigen varies between different bacterial strains and provides antigenic specificity aiding in the diagnosis of active infection. 

How Do Lipopolysaccharides (LPS) Contribute to Diseases?

LPS enters the blood through a bacterial infection and leads to a series of immune reactions.

  1. Secretion of several pro-inflammatory cytokines through activation of toll-like receptors (TLRs).
  2. After the TLRs recognize the LPS it causes the release of inflammatory cytokines such as tumor necrosis factor-alpha (TNF-a), IL-6, and IL-8
  3. Once the cytokines are released into the bloodstream, they cause widespread inflammation and activation of reactive oxygen species (ROS), which produces an overwhelming immune response and oxidative stress in the body. 
  4. The severity of the immune response can lead to cell damage with potentially lethal effects. 

The following are common health issues associated with high levels of endotoxin exposure:

How to Treat Endotoxin-Induced Conditions

The medical approach to treating endotoxin illness primarily focuses on using targeted antibiotics to eradicate the underlying bacterial infection alongside supportive therapies to manage inflammation and prevent complications.

The Medical Approach to Treating Endotoxin-Induced Conditions

Antibiotics: 

Gram-negative bacteria that contain LPS are some of the hardest infections to treat due to antibiotic resistance. Conventional antibiotic therapy for gram-negative bacteria effectively kills the bacteria but does not effectively neutralize LPS. 

Among antibiotics currently being used for endotoxin-induced conditions are beta-lactam antibiotics such as carbapenems, which have shown a reduced risk of sepsis. For less severe infections caused by gram-negative bacteria, the use of fluoroquinolones and aminoglycoside antibiotics has shown efficacy if started promptly. 

Endotoxin Neutralization: 

An alternative strategy to managing endotoxin-related illness is through neutralizing the LPS. This can be accomplished with Polymyxin B, an antibiotic that can kill gram-negative bacteria and bind circulating endotoxin without causing systemic toxicity. 

Polymixin drugs target the bacterial cell membrane causing bacterial lethality, however, they can cause nephrotoxicity and neurotoxicity. For this reason, polymyxin use is limited and only reserved as a last-line treatment for endotoxin-related illness. 

Anti-inflammatory Medications: 

Endotexmia can cause widespread inflammation in the body causing serious complications. While antibiotics are necessary for treatment, incorporating medications to reduce inflammation is crucial. 

  • Anti-inflammatory medications such as NSAIDs and corticosteroids can help diminish the inflammation caused by endotoxin illness. 
  • Low-dose hydrocortisone is effective in reducing cytokine production and systemic inflammation caused by endotoxemia (2). 

The Complementary Approach to Support Treatments of Endotoxin-Induced Conditions

Probiotics and Gut Health: 

Endotexmia develops when endotoxins such as LPS reach the bloodstream due to increased intestinal permeability. Intestinal permeability can allow harmful microorganisms and toxins to enter the bloodstream. Maintaining a healthy microbiome and implementing probiotics can help strengthen the gut wall, reducing endotoxin production and the chance of endotoxins reaching the bloodstream. 

Spore-based probiotics such as Bacillus indicus, Bacillus subtilis, and Bacillus coagulans reduce symptoms of leaky gut syndrome. These spore-based probiotics are associated with a 45% reduction in endotoxin levels in the blood. Lactobacillus probiotics are also effective in maintaining a healthy gut wall by enhancing goblet cells, a mechanism used to enhance barrier function (1). 

Implementing nutraceuticals such as L-glutamine helps regulate tight junctions in the gut which reduces intestinal permeability and reduces intestinal endotoxin levels. Polyphenols such as quercetin, curcumin, and resveratrol also enhance tight junction integrity, improving intestinal permeability.

Dietary Modifications: 

Making dietary changes to reduce processed foods and incorporating anti-inflammatory foods can help heal leaky gut and aid in preventing and treating endotoxin-related illnesses. The following are dietary recommendations to reduce inflammation and heal leaky gut:

  • Decrease intake of processed carbohydrates such as sweetened beverages, bread, snack foods, and alcohol, as these foods are associated with a decreased microbiome diversity
  • Incorporate foods high in fiber, such as fruit and vegetables
  • Including coffee, tea, and red wine in moderation helps increase beneficial bifidobacteria in the gut
  • Decrease intake of fermentable oligosaccharides (FODMAPs) such as fructans, sorbitol, and xylitol as they lead to intestinal inflammation and a weakened gut wall.
  • Increasing intake of yogurt can help protect the intestinal epithelium
  • Medicinal mushrooms such as Chaga can modulate gut microbiota and decrease intestinal inflammation

Hydration and Detoxification: 

Incorporating detoxification strategies can assist in flushing out bacterial toxins from the body. 

  • Focus on activities that make you sweat, such as physical exercise and sauna use, to help decrease total toxin load (5)
  • Increasing hydration helps support the kidneys in filtering out bacterial toxins and waste products from the blood
  • Supporting liver detox with berberine, milk thistle, and glutathione (41)
  • Castor oil packs over the liver decrease inflammation and support detoxification

Innovative Research and Emerging Treatments

Toll-like receptor 4 (TLR4) is the main signaling pathway in endotoxin-related illness. Modulation of the TLR4 pathway through natural and synthetic sources is an emerging strategy to reduce bacterial endotoxin disease. 

  • Berberine blocks the TLR4 pathway and reduces NF-Kb signaling, leading to decreased systemic inflammation.
  • Humulus lupulus (Hops) has shown anti-inflammatory effects by blocking TLR4 activation
  • Sulforaphane, naturally found in cruciferous vegetables, blocks LPS interaction with TLR4 receptors
  • Synthetic compounds such as resatorvid and eritoran block TLR4 activity by mimicking the lipid A portion of LPS

Gene Therapy and Molecular Techniques

Gene therapy and molecular techniques for endotoxin-related illnesses are an emerging area of research that aims to address the underlying mechanisms of immune response and inflammation triggered by LPS. Anti-microbial peptides (AMPs) such as cathelicidin, have shown promising efficacy in the neutralization of gram-negative bacteria (42). 

[signup]

Key Takeaways

  • Lipopolysaccharides (LPS), also known as endotoxins, are a major component of gram-negative bacteria and trigger a severe immune response and systemic inflammation
  • Endotoxins can cause a wide range of systemic health issues, from mild inflammation, fever, poor gut health, chronic pain/fatigue, cardiovascular disorders, and autoimmunity.
  • Incorporating dietary, nutraceutical, and detoxification strategies can greatly help decrease inflammation in endotoxin-related illnesses.
  • Emerging research in herbal medicine, pharmaceuticals, and peptide therapy shows promising therapeutic potential in regulating inflammation caused by LPS immune activation.

Lipopolysaccharides (LPS), or endotoxins, are components of the outer membrane of Gram-negative bacteria that can provoke significant immune responses when they enter the human body, potentially leading to various health concerns. 

This article discusses the potential health impacts of LPS exposure and strategies for managing conditions associated with endotoxin exposure, encompassing both medical and lifestyle considerations. 

[signup]

What Are Lipopolysaccharides (LPS)? 

Lipopolysaccharides (LPS) are components of the outer cell membrane of gram-negative bacteria. The gram-negative bacterial cell membrane consists of an inner and outer membrane. LPS molecules are considered bacterial toxins. When they enter the body during an infection, they can trigger a significant immune reaction.

LPS are composed of three main parts: Lipid A, which is the most virulent factor, O-antigen, and a hydrophilic core. The O-antigen varies between different bacterial strains and provides antigenic specificity, which can aid in the diagnosis of active infection. 

How Do Lipopolysaccharides (LPS) Contribute to Health Concerns?

LPS enters the blood through a bacterial infection and can lead to a series of immune reactions.

  1. Secretion of several pro-inflammatory cytokines through activation of toll-like receptors (TLRs).
  2. After the TLRs recognize the LPS, it may cause the release of inflammatory cytokines such as tumor necrosis factor-alpha (TNF-a), IL-6, and IL-8
  3. Once the cytokines are released into the bloodstream, they may contribute to widespread inflammation and activation of reactive oxygen species (ROS), which can produce an overwhelming immune response and oxidative stress in the body. 
  4. The severity of the immune response can potentially lead to cell damage with serious effects. 

The following are common health concerns associated with high levels of endotoxin exposure:

How to Manage Endotoxin-Related Health Concerns

The medical approach to managing endotoxin-related health concerns primarily focuses on using targeted antibiotics to address the underlying bacterial infection alongside supportive therapies to help manage inflammation and reduce the risk of complications.

The Medical Approach to Managing Endotoxin-Related Health Concerns

Antibiotics: 

Gram-negative bacteria that contain LPS can be challenging to address due to antibiotic resistance. Conventional antibiotic therapy for gram-negative bacteria may effectively address the bacteria but does not effectively neutralize LPS. 

Among antibiotics currently being used for endotoxin-related health concerns are beta-lactam antibiotics such as carbapenems, which have shown a reduced risk of sepsis. For less severe infections caused by gram-negative bacteria, the use of fluoroquinolones and aminoglycoside antibiotics has shown efficacy if started promptly. 

Endotoxin Neutralization: 

An alternative strategy to managing endotoxin-related health concerns is through neutralizing the LPS. This can be accomplished with Polymyxin B, an antibiotic that can address gram-negative bacteria and bind circulating endotoxin without causing systemic toxicity. 

Polymixin drugs target the bacterial cell membrane, potentially causing bacterial lethality; however, they can cause nephrotoxicity and neurotoxicity. For this reason, polymyxin use is limited and only reserved as a last-line option for endotoxin-related health concerns. 

Anti-inflammatory Medications: 

Endotoxemia can cause widespread inflammation in the body, potentially leading to serious complications. While antibiotics may be necessary, incorporating medications to help reduce inflammation can be crucial. 

  • Anti-inflammatory medications such as NSAIDs and corticosteroids may help diminish the inflammation associated with endotoxin exposure. 
  • Low-dose hydrocortisone has been shown to be effective in reducing cytokine production and systemic inflammation associated with endotoxemia (2). 

Complementary Approaches to Support Management of Endotoxin-Related Health Concerns

Probiotics and Gut Health: 

Endotoxemia may develop when endotoxins such as LPS reach the bloodstream due to increased intestinal permeability. Intestinal permeability can allow harmful microorganisms and toxins to enter the bloodstream. Maintaining a healthy microbiome and considering probiotics may help support the gut wall, potentially reducing endotoxin production and the chance of endotoxins reaching the bloodstream. 

Spore-based probiotics such as Bacillus indicus, Bacillus subtilis, and Bacillus coagulans may help manage symptoms of leaky gut syndrome. These spore-based probiotics have been associated with a 45% reduction in endotoxin levels in the blood. Lactobacillus probiotics may also be effective in supporting a healthy gut wall by enhancing goblet cells, a mechanism used to enhance barrier function (1). 

Considering nutraceuticals such as L-glutamine may help regulate tight junctions in the gut, which could support reduced intestinal permeability and lower intestinal endotoxin levels. Polyphenols such as quercetin, curcumin, and resveratrol may also enhance tight junction integrity, potentially improving intestinal permeability.

Dietary Modifications: 

Making dietary changes to reduce processed foods and incorporating anti-inflammatory foods may help support gut health and aid in managing endotoxin-related health concerns. The following are dietary considerations to support reduced inflammation and gut health:

  • Consider decreasing intake of processed carbohydrates such as sweetened beverages, bread, snack foods, and alcohol, as these foods are associated with decreased microbiome diversity
  • Incorporate foods high in fiber, such as fruits and vegetables
  • Including coffee, tea, and red wine in moderation may help increase beneficial bifidobacteria in the gut
  • Consider decreasing intake of fermentable oligosaccharides (FODMAPs) such as fructans, sorbitol, and xylitol as they may lead to intestinal inflammation and a weakened gut wall.
  • Increasing intake of yogurt may help support the intestinal epithelium
  • Medicinal mushrooms such as Chaga may help modulate gut microbiota and decrease intestinal inflammation

Hydration and Detoxification: 

Incorporating detoxification strategies may assist in supporting the body's natural processes for managing bacterial toxins. 

  • Focus on activities that promote sweating, such as physical exercise and sauna use, which may help support the body's natural detoxification processes (5)
  • Increasing hydration may help support the kidneys in filtering out bacterial toxins and waste products from the blood
  • Supporting liver health with berberine, milk thistle, and glutathione (41)
  • Castor oil packs over the liver may help decrease inflammation and support detoxification

Innovative Research and Emerging Approaches

Toll-like receptor 4 (TLR4) is the main signaling pathway in endotoxin-related health concerns. Modulation of the TLR4 pathway through natural and synthetic sources is an emerging strategy to support the body's response to bacterial endotoxin exposure. 

  • Berberine may help block the TLR4 pathway and reduce NF-Kb signaling, potentially leading to decreased systemic inflammation.
  • Humulus lupulus (Hops) has shown potential anti-inflammatory effects by blocking TLR4 activation
  • Sulforaphane, naturally found in cruciferous vegetables, may help block LPS interaction with TLR4 receptors
  • Synthetic compounds such as resatorvid and eritoran may help block TLR4 activity by mimicking the lipid A portion of LPS

Gene Therapy and Molecular Techniques

Gene therapy and molecular techniques for endotoxin-related health concerns are an emerging area of research that aims to address the underlying mechanisms of immune response and inflammation triggered by LPS. Anti-microbial peptides (AMPs) such as cathelicidin, have shown promising potential in the neutralization of gram-negative bacteria (42). 

[signup]

Key Takeaways

  • Lipopolysaccharides (LPS), also known as endotoxins, are a major component of gram-negative bacteria and can trigger a significant immune response and systemic inflammation
  • Endotoxins may contribute to a wide range of systemic health concerns, from mild inflammation, fever, poor gut health, chronic pain/fatigue, cardiovascular disorders, and autoimmunity.
  • Incorporating dietary, nutraceutical, and detoxification strategies may help support reduced inflammation in endotoxin-related health concerns.
  • Emerging research in herbal medicine, pharmaceuticals, and peptide therapy shows promising potential in supporting the regulation of inflammation associated with LPS immune activation.
The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.

Learn more

No items found.

Lab Tests in This Article

No lab tests!
  1. Aleman, R. S., Moncada, M., & Aryana, K. J. (2023). Leaky Gut and the Ingredients That Help Treat It: A Review. Molecules, 28(2), 619. https://doi.org/10.3390/molecules28020619
  2. Alvarez, S. M., Maria Katsamanis Karavidas, Coyle, S. M., Lu, S.-E., Macor, M., Oikawa, L. O., Lehrer, P. M., Calvano, S. E., & Lowry, S. F. (2007). Low-dose steroid altersin vivoendotoxin-induced systemic inflammation but does not influence autonomic dysfunction. Journal of Endotoxin Research, 13(6), 358–368. https://doi.org/10.1177/0968051907086465
  3. Aminoglycosides - Infectious Diseases. (n.d.). Merck Manuals Professional Edition. https://www.merckmanuals.com/professional/infectious-diseases/bacteria-and-antibacterial-drugs/aminoglycosides
  4. Bertanga, B. (2024, January 4). Understanding the Potential Benefits of Milk Thistle for Fatty Liver. Rupa Health. https://www.rupahealth.com/post/understanding-the-potential-benefits-of-milk-thistle-for-fatty-liver
  5. Bonakdar, R., Sweeney, M., Dalhoumi, S., Adair, V., Garvey, C., Hodge, T., Herrala, L., Barbee, A., Case, C., Kearney, J., Ma, C., Smith, K., Hwang, J., Robert, N., Bonakdar, A., Scripps, C., Ma, S., & Living. (2020). 16 Bonakdar-Detoxification Enhanced Lifestyle Intervention. Integrative Medicine •, 19(5). https://my.standardprocess.com/Standard-Process-Document-Library/Handouts/SP-Detox-Balance-Integrative-Medicine-Journal.pdf
  6. Brandenburg, K., Schromm, A. B., Weindl, G., Heinbockel, L., Correa, W., Mauss, K., Martinez de Tejada, G., & Garidel, P. (2020). An update on endotoxin neutralization strategies in Gram-negative bacterial infections. Expert Review of Anti-Infective Therapy, 19(4), 495–517. https://doi.org/10.1080/14787210.2021.1834847
  7. Carbapenems - Infectious Diseases. (n.d.). Merck Manuals Professional Edition. https://www.merckmanuals.com/professional/infectious-diseases/bacteria-and-antibacterial-drugs/carbapenems
  8. Christie, J. (2022, August 15). It’s Time To Start Treating Coffee Like A Health Food. Rupa Health. https://www.rupahealth.com/post/its-time-to-start-treating-coffee-like-a-health-food
  9. Cloyd, J. (2023a, February 28). A Functional Medicine Protocol for Leaky Gut Syndrome. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-protocol-for-leaky-gut-syndrome
  10. Cloyd, J. (2023b, April 5). Treatment of Antibiotic Resistance Through Functional Medicine. Rupa Health. https://www.rupahealth.com/post/treatment-of-antibiotic-resistance-through-functional-medicine
  11. Cloyd, J. (2023c, May 10). Unlocking the Secrets of Lactobacillus: A Comprehensive Guide to Testing Patient Levels and Deciphering High and Low Levels. Rupa Health. https://www.rupahealth.com/post/lactobacillus-101-how-to-test-your-patients-levels-and-understand-high-and-low-levels
  12. Cloyd, J. (2023d, June 19). A Functional Medicine Post Stroke Protocol: Testing, Therapeutic Diet, and Integrative Therapy Options. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-post-stroke-protocol-testing-supplements-and-integrative-therapy-options
  13. Cloyd, J. (2023e, July 7). Integrative Approaches to Reducing Toxin Exposure in Everyday Life. Rupa Health. https://www.rupahealth.com/post/integrative-approaches-to-reducing-toxin-exposure-in-everyday-life
  14. Cloyd, J. (2023f, November 8). Quercetin 101: Getting to Know This Powerful Substance and How You Can Use it For Your Health. Rupa Health. https://www.rupahealth.com/post/quercetin-101-getting-to-know-this-powerful-substance-and-how-you-can-use-it-for-your-health
  15. Cloyd, J. (2023g, December 5). Inflammation and Heart Disease: A Functional Medicine Approach to Prevention and Treatment. Rupa Health. https://www.rupahealth.com/post/inflammation-and-heart-disease-a-functional-medicine-approach-to-prevention-and-treatment
  16. Cloyd, J. (2024, January 11). Integrating Resveratrol for Improved Insulin Sensitivity and Endocrine Health. Rupa Health. https://www.rupahealth.com/post/integrating-resveratrol-for-improved-insulin-sensitivity-and-endocrine-health
  17. Cloyd, K. (2023, December 20). Interpreting Oxidative Stress Markers. Rupa Health. https://www.rupahealth.com/post/interpreting-oxidative-stress-markers
  18. Connor, V. (2022, October 11). 6 Complementary and Alternative Therapies for Chronic Fatigue Syndrome. Rupa Health. https://www.rupahealth.com/post/6-natural-therapies-that-can-help-with-chronic-fatigue-symptoms
  19. Daglis, S. (2024, April 16). Berberine 101: What It Is, Benefits, and Side Effects. Rupa Health. https://www.rupahealth.com/post/berberine-101-what-it-is-benefits-and-side-effects
  20. Dao, D.-P. D., & Le, P. H. (2020). Histology, Goblet Cells. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK553208/
  21. DePorto, T. (2023, January 31). Glutathione Health Benefits: The Master Antioxidant. Rupa Health. https://www.rupahealth.com/post/glutathione-health-benefits-the-master-antioxidant
  22. Duan, T., Du, Y., Xing, C., Wang, H. Y., & Wang, R.-F. (2022). Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.812774
  23. DynaMedex. (n.d.). Www.dynamedex.com. Retrieved May 19, 2024, from https://www.dynamedex.com/condition/bacteremia-with-gram-negative-bacilli-1#TIME_TO_APPROPRIATE_ANTIBIOTIC_THERAPY
  24. Farhana, A., & Khan, Y. S. (2020). Biochemistry, Lipopolysaccharide. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK554414/
  25. Fluoroquinolones - Infectious Diseases. (n.d.). Merck Manuals Professional Edition. https://www.merckmanuals.com/professional/infectious-diseases/bacteria-and-antibacterial-drugs/fluoroquinolones
  26. Garrison, K. (2024, April 30). How Castor Oil Can Complement Your Anti-Inflammatory Treatment Plan. Rupa Health. https://www.rupahealth.com/post/how-castor-oil-can-complement-your-anti-inflammatory-treatment-plan
  27. Glutamine. (n.d.). Rupa Health. Retrieved May 19, 2024, from https://www.rupahealth.com/biomarkers/glutamine
  28. Greenan, S. (2021, November 18). How To Do A Low FODMAP Elimination Diet. Rupa Health. https://www.rupahealth.com/post/what-are-fodmaps
  29. Hills, R. D., Pontefract, B. A., Mishcon, H. R., Black, C. A., Sutton, S. C., & Theberge, C. R. (2019). Gut Microbiome: Profound Implications for Diet and Disease. Nutrients, 11(7), 1613. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682904/
  30. Interleukin 8. (n.d.). Rupa Health. https://www.rupahealth.com/biomarkers/interleukin-8
  31. Jung, F., Staltner, R., Baumann, A., Burger, K., Halilbasic, E., Hellerbrand, C., & Bergheim, I. (2022). A Xanthohumol-Rich Hop Extract Diminishes Endotoxin-Induced Activation of TLR4 Signaling in Human Peripheral Blood Mononuclear Cells: A Study in Healthy Women. International Journal of Molecular Sciences, 23(20), 12702. https://doi.org/10.3390/ijms232012702
  32. Khakham MBA, NMD , C. (2023, October 9). Gut Health and Medicinal Mushrooms: Exploring the Gut-Immune Connection. Rupa Health. https://www.rupahealth.com/post/gut-health-and-medicinal-mushrooms-exploring-the-gut-immune-connection
  33. Khakham, C. (2023a, March 7). Top Medical Evidence Supporting Curcumin’s Health Benefits. Rupa Health. https://www.rupahealth.com/post/top-medical-evidence-supporting-curcumins-health-benefits
  34. Khakham, C. (2023b, May 23). A Comprehensive Review of IBS-D: Differential Diagnosis, Specialty Testing, and Integrative Treatment Options. Rupa Health. https://www.rupahealth.com/post/a-comprehensive-review-of-ibs-d-differential-diagnosis-specialty-testing-and-integrative-treatment-options
  35. Khakham, C. (2023c, May 23). An integrative medicine approach to alzheimer’s disease: Testing, nutrition, and supplements. Rupa Health. https://www.rupahealth.com/post/to-functional-medicine-labs-that-help-individualize-treatment-for-alzheimers-disease
  36. Koo, J. E., Park, Z.-Y., Kim, N. D., & Lee, J. Y. (2013). Sulforaphane inhibits the engagement of LPS with TLR4/MD2 complex by preferential binding to Cys133 in MD2. Biochemical and Biophysical Research Communications, 434(3), 600–605. https://doi.org/10.1016/j.bbrc.2013.03.123
  37. Kresge, K. (2022, April 15). 4 Possible Causes Of Parkinson’s And 5 Things That Make It Worse. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-parkinsons-disease
  38. Kuzmich, N., Sivak, K., Chubarev, V., Porozov, Y., Savateeva-Lyubimova, T., & Peri, F. (2017). TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis. Vaccines, 5(4), 34. https://doi.org/10.3390/vaccines5040034
  39. Maholy, N. (2023, June 29). The Role of Probiotics and Prebiotics in Gut Health: An Integrative Perspective. Rupa Health. https://www.rupahealth.com/post/the-role-of-probiotics-and-prebiotics-in-gut-health-an-integrative-perspective
  40. McFarlin, B. K., Henning, A. L., Bowman, E. M., Gary, M. A., & Carbajal, K. M. (2017). Oral spore-based probiotic supplementation was associated with reduced incidence of post-prandial dietary endotoxin, triglycerides, and disease risk biomarkers. World Journal of Gastrointestinal Pathophysiology, 8(3), 117. https://doi.org/10.4291/wjgp.v8.i3.117
  41. Methiye Mancak. (2023). Evidence-based herbal treatments in liver diseases. Hepatology Forum/Hepatology Forum (Online), 50–60. https://doi.org/10.14744/hf.2022.2022.0052
  42. Mohammad, S., & Thiemermann, C. (2021). Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions. Frontiers in Immunology, 11. https://doi.org/10.3389/fimmu.2020.594150
  43. Mohapatra, S. S., Dwibedy, S. K., & Padhy, I. (2021). Polymyxins, the last-resort antibiotics: Mode of action, resistance emergence, and potential solutions. Journal of Biosciences, 46(3). https://doi.org/10.1007/s12038-021-00209-8
  44. Molteni, M., Bosi, A., & Rossetti, C. (2018). Natural Products with Toll-Like Receptor 4 Antagonist Activity. International Journal of Inflammation, 2018, 1–9. https://doi.org/10.1155/2018/2859135
  45. Neibling, K. (2023, April 26). Complementary and Integrative Medicine Treatments for Hypertension and Cardiovascular Disease. Rupa Health. https://www.rupahealth.com/post/complementary-and-integrative-medicine-treatments-for-hypertension-and-cardiovascular-disease
  46. Neilburg, K. (2023, April 17). An Integrative Medicine Approach to ALS Treatment. Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-approach-to-als-treatment
  47. Page, M. J., Kell, D. B., & Pretorius, E. (2022). The Role of Lipopolysaccharide-Induced Cell Signalling in Chronic Inflammation. Chronic Stress, 6, 24705470221076390. https://doi.org/10.1177/24705470221076390
  48. Pandolfi, F., Franza, L., Carusi, V., Altamura, S., Andriollo, G., & Nucera, E. (2020). Interleukin-6 in Rheumatoid Arthritis. International Journal of Molecular Sciences, 21(15), 5238. https://doi.org/10.3390/ijms21155238
  49. Perera MD, H. (2024, April 11). The Ultimate Fiber Foods List: Boost Your Health with High-Fiber Choices. Rupa Health. https://www.rupahealth.com/post/ultimate-fiber-foods-list
  50. Preston, J. (2023, September 22). Addressing Inflammation in Chronic Diseases: A Functional Medicine Perspective. Rupa Health. https://www.rupahealth.com/post/addressing-inflammation-in-chronic-diseases-a-functional-medicine-perspective
  51. Preston, J. (2024, February 1). Integrative Approach to Chronic Inflammatory Response Syndrome (CIRS). Rupa Health. https://www.rupahealth.com/post/integrative-approach-to-chronic-inflammatory-response-syndrome-cirs
  52. Stanford, J. (2024, February 19). The Hidden Perils of Refined Carbohydrates: What Every Healthcare Professional Needs to Know. Rupa Health. https://www.rupahealth.com/post/the-hidden-perils-of-refined-carbohydrates-what-every-healthcare-professional-needs-to-know
  53. Tani, T., Shimizu, T., Tani, M., Shoji, H., & Endo, Y. (2019). Anti-endotoxin Properties of Polymyxin B-immobilized Fibers. Advances in Experimental Medicine and Biology, 1145, 321–341. https://doi.org/10.1007/978-3-030-16373-0_19
  54. Tumor Necrosis Factor Alpha. (n.d.). Rupa Health. Retrieved May 19, 2024, from https://www.rupahealth.com/biomarkers/tumor-necrosis-factor-alpha
  55. van Harten, R., van Woudenbergh, E., van Dijk, A., & Haagsman, H. (2018). Cathelicidins: Immunomodulatory Antimicrobials. Vaccines, 6(3), 63. https://doi.org/10.3390/vaccines6030063
  56. Villegas, M. V., & Lyon, S. (2018). Gram-negative infections: evolving treatments with expanding options. Future Science OA, 4(9), FSO339. https://doi.org/10.4155/fsoa-2018-0071
  57. Wassenaar, T. M., & Zimmermann, K. (2018). Lipopolysaccharides in food, food supplements, and probiotics: should we be worried? European Journal of Microbiology and Immunology, 8(3), 63–69. https://doi.org/10.1556/1886.2018.00017
  58. Weinberg, J. (2023a, January 11). How To Test Your Patients For Metabolic Syndrome. Rupa Health. https://www.rupahealth.com/post/how-to-test-your-patients-for-metabolic-syndrome-a-functional-medicie-approach
  59. Weinberg, J. (2023b, December 26). The Power of Polyphenols: Functional Medicine’s Antioxidant Superstars. Rupa Health. https://www.rupahealth.com/post/the-power-of-polyphenols-functional-medicines-antioxidant-superstars
  60. Yoshimura, H. (2023, December 18). Exploring the Connection Between Chronic Pain and Emotional Wellbeing in Functional Medicine. Rupa Health. https://www.rupahealth.com/post/exploring-the-connection-between-chronic-pain-and-emotional-wellbeing-in-functional-medicine
  61. Yoshimura, H. (2024, April 8). Evidence-Based Review: The Role of Anti-Inflammatory Foods. Rupa Health. https://www.rupahealth.com/post/evidence-based-review-the-role-of-anti-inflammatory-foods
  62. Yusra Habib Khan, Aroosa Liaqat, Tauqeer Hussain Mallhi, Abid, A., Nasser Hadal Alotaibi, & Khan, A. (2021). Bacterial Endotoxins and Neurological Disorders: From Exposure to Therapeutic Interventions. Emerging Contaminants and Associated Treatment Technologies, 49–67. https://doi.org/10.1007/978-3-030-66376-6_3
  63. Zhang, J.-M., & An, J. (2007). Cytokines, Inflammation, and Pain. International Anesthesiology Clinics, 45(2), 27–37. https://doi.org/10.1097/AIA.0b013e318034194e
Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Toxins
Subscribe to the Magazine for free
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey Practitioners! Ready to become a world class gut health expert? Join Jeannie Gorman, MS, CCN, for a Free Live Class that dives into how popular diets impact the gut microbiome, the clinical dietary needs of your gut, biomarkers to test to analyze gut health, and gain a clear understanding of the Doctor’s Data GI360™ profile. Register here.